BIIB

Trade Biogen Inc. - BIIB stock price

1m
5m
15m
30m
1H
4H
1D
1W
History

BIIB

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis (MS); FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), and other conditions; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies. The company's Phase II clinical trial products comprise Opicinumab for MS; BAN2401 for Alzheimer's disease; BIIB092 for PSP; Natalizumab for Acute Ischemic Stroke and Epilepsy; and BG00011 for idiopathic pulmonary fibrosis. Its Phase I/IIa clinical trial products consist of BIIB080 for patients with mild AD. The company's Phase I clinical trial products comprise Aducanumab for Alzheimer's disease; BIIB076, an anti-tau monoclonal antibody; and BIIB054 for Parkinson's disease. Biogen Inc. offers products through its sales force and marketing groups. The company was formerly known as Biogen Idec Inc. and changed its name to Biogen Inc. in March 2015. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.
White Paper Declaration
iPhone Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat
iMac Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat
iMac Image
1BTC
Invest
20BTC
Profit
Leverage:
x20
The Power Of Leverage
Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

BIIB price history

Date Close Change Change(%) Open High Low
Jan 21, 2022 220.14 -5.01 -2.23% 225.15 225.81 220.14
Jan 20, 2022 225.73 -4.92 -2.13% 230.65 232.86 225.44
Jan 19, 2022 230.59 -3.25 -1.39% 233.84 234.82 230.47
Jan 18, 2022 233.67 -3.18 -1.34% 236.85 236.85 231.14
Jan 14, 2022 239.08 5.16 2.21% 233.92 239.29 233.45
Jan 13, 2022 236.38 11.22 4.98% 225.16 239.49 225.16
Jan 12, 2022 225.12 3.23 1.46% 221.89 227.40 216.96
Jan 11, 2022 241.27 6.01 2.55% 235.26 243.51 234.31
Jan 10, 2022 234.92 3.39 1.46% 231.53 235.28 230.30
Jan 7, 2022 232.46 -2.73 -1.16% 235.19 236.53 231.47
Jan 6, 2022 237.13 -2.13 -0.89% 239.26 242.16 236.62
Jan 5, 2022 239.11 -1.87 -0.78% 240.98 248.66 238.90
Jan 4, 2022 241.39 -2.89 -1.18% 244.28 244.98 238.85
Jan 3, 2022 243.94 4.14 1.73% 239.80 247.36 237.86
Dec 31, 2021 239.80 0.32 0.13% 239.48 243.52 238.86
Dec 30, 2021 239.86 -4.98 -2.03% 244.84 246.48 236.88
Dec 29, 2021 258.10 23.79 10.15% 234.31 265.13 233.79
Dec 28, 2021 235.77 2.91 1.25% 232.86 236.77 232.86
Dec 27, 2021 233.94 -0.93 -0.40% 234.87 236.44 232.21
Dec 23, 2021 234.95 2.06 0.88% 232.89 235.93 231.87